Eli Lilly and Company · Indianapolis, IN United States (NYSE: LLY)
| Lilly Corporate Center, 893 S. Delaware St. | Phone: 317-276-2000 |
| Indianapolis, IN | Fax: 317-276-4878 |
| 46285 | |
| United States | 
Map This Company |
Eli Lilly and Company Rankings
 #115 in FORTUNE 500 (May 2011) | S&P 500 | #197 in FT Global 500 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Eli Lilly hopes everything will come up roses for you, healthwise. Although best known for its neurological therapies, the company develops medicines for a wide variety of ailments. Its top drugs include Zyprexa (schizophrenia and bipolar disorder), Cymbalta (depression), cancer treatments Gemzar and Alimta, and endocrinology (hormone-related) products such as Humalog insulin and osteoporosis medication Evista. Lilly also makes cardiovascular therapies and anti-infective agents, as well as animal health products. The company sells its products in some 140 countries.
Eli Lilly and Company Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NYSE: LLY Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 38,350 |
Executives
555 executives listed for Eli Lilly and Company's Indianapolis, IN location.
| Chairman, President, and CEO | John Lechleiter | |
|---|---|---|
| Principal | Kerry Dunlavey | |
| EVP Global Services and CFO | Derica Rice |